latest news releases from the newsroom
Lantronix, Inc. Retains The Piacente Group as Investor Relations Counsel
IRVINE, Calif., Nov. 10, 2005 (PRIMEZONE) -- Lantronix, Inc. (Nasdaq:LTRX), a leading provider of hardware and software networking solutions, announced today that it has retained The Piacente Group, Inc., a full service investor relations and financial communications consulting firm based in New York, to provide strategic investor relations services.
Dietert Senior Center
Photo Release -- Kerrville Senior Citizens Drop Everything for a Good Cause
HOUSTON, Nov. 10, 2005 (PRIMEZONE) -- Anyone who hears the words "senior citizens" and thinks of walkers and nursing homes doesn't know the Kerrville "Mild Bunch." After recognizing a dire need for a new senior community center in Kerr County, fifteen high-profile community leaders of Kerrville, Texas came together to help raise money for a new facility to replace the 36-year-old Dietert Senior Center (DSC). The group developed a unique and undeniably risque method of fundraising for the $4 million capital campaign project, which required the "Mild Bunch" to drop everything -- including their pants.
Scientific Industries Announces Higher Sales and 65 Percent Increase in Net Income for First Quarter
BOHEMIA, N.Y., Nov. 10, 2005 (PRIMEZONE) -- Scientific Industries Inc. (OTCBB:SCND) reported today a 65% increase in net income and moderately higher sales for the three months ended September 30, 2005 compared to the three months ended September 30, 2004. The significant increase in the Company's profitability resulted from the higher sales and especially higher gross margins compared to the same period last year, with the Company's operating expenses only slightly higher than the previous year.
StockGuru.com Issues New Profile Report on Response Biomedical Corporation Authored by Shailesh Dhuri, CFA
DALLAS, Nov. 10, 2005 (PRIMEZONE) -- StockGuru.com has issued a Profile Report on Response Biomedical Corporation (OTCBB:RPBIF) (TSX-V:RBM), a leading diagnostics company commercializing rapid clinical and environmental tests on its proprietary RAMP platform. The report is authored by Shailesh Dhuri, CFA and Senior Financial Analyst for Pentony Enterprises. The report discusses the company's relationships with 3M Health Care, Roche Diagnostics and the new opportunities developed in the market due to the threat of avian flu.
ViroPharma to Host Conference Call to Discuss Clinical Results of HCV-796
EXTON, Pa., Nov. 10, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that the company will host a conference call and live audio webcast today at 4:30 p.m. to discuss the results of the Phase 1b study with HCV-796, an orally dosed hepatitis C (HCV) viral polymerase inhibitor with the potential to interfere with the replication of HCV, that is being co-developed with Wyeth Pharmaceuticals, a division of Wyeth.